# Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission

> **NCT00213083** · PHASE3 · COMPLETED · sponsor: **Population Council** · enrollment: 6203 (actual)

## Conditions studied

- HIV Infections
- AIDS
- Sexually Transmitted Diseases
- HIV Seroconversion

## Interventions

- **DRUG:** Carraguard (PC-515)

## Key facts

- **NCT ID:** NCT00213083
- **Lead sponsor:** Population Council
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 6203 (ACTUAL)
- **Last updated:** 2017-08-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213083, "Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00213083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*